VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
BLCO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
BLCOBausch + Lomb Corporation
$17.05$6.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBLCOFinancials

Bausch + Lomb Corporation (BLCO) Income Statement

7Y historyFree accessUpdated daily

Revenue growth accelerated to 8.7% YoY in 2026Q2 with gross margin expanding to 59.1% from 53.7% a year earlier, though net losses persist at -$10M for the quarter.

Income StatementBalance SheetCash FlowRatios

BLCO Income Statement

Annual statement

BLCO Income Statement

Bausch + Lomb Corporation (BLCO) annual income statement — 7-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Sales/Revenue5.32B5.1B4.79B4.15B3.77B3.77B3.41B3.78B
Revenue Growth %8.75%6.47%15.56%10.03%0.08%10.35%-9.69%-
Cost of Goods Sold2.27B2.31B1.87B1.64B1.52B1.47B1.28B1.33B
COGS % of Revenue-45.25%39.07%39.6%40.31%38.96%37.66%35.12%
Gross Profit3.04B2.79B2.92B2.5B2.25B2.3B2.13B2.45B
Gross Margin %57.23%54.75%60.93%60.4%59.69%61.04%62.34%64.88%
Gross Profit Growth %--4.32%16.57%11.34%-2.13%8.04%-13.22%-
Operating Expenses2.66B2.6B2.76B2.37B2.04B1.97B1.87B2.06B
OpEx % of Revenue-51.07%57.55%57.26%54.19%52.3%54.72%54.39%
Selling, General & Admin2.22B2.23B2.08B1.74B1.48B1.39B1.25B1.38B
SG&A % of Revenue-43.8%43.46%41.87%39.23%36.89%36.72%36.58%
Research & Development404M371M343M324M307M271M281M258M
R&D % of Revenue-7.27%7.16%7.81%8.15%7.2%8.24%6.83%
Other Operating Expenses1000K0332M314M257M309M333M415M
Operating Income380M188M162M130M207M329M260M396M
Operating Margin %7.14%3.69%3.38%3.14%5.49%8.74%7.62%10.48%
Operating Income Growth %-16.05%24.62%-37.2%-37.08%26.54%-34.34%-
EBITDA791M609M598M512M586M744M702M865M
EBITDA Margin %14.87%11.94%12.48%12.35%15.55%19.76%20.57%22.9%
EBITDA Growth %55.4%1.84%16.8%-12.63%-21.24%5.98%-18.84%-
D&A (Non-Cash Add-back)411M421M436M382M379M415M442M469M
EBIT331M114M165M117M219M318M290M467M
Net Interest Income-382M-419M-384M-268M-140M03M1M
Interest Income14M12M15M15M6M03M1M
Interest Expense396M431M399M283M146M000
Other Income/Expense-445M-505M-396M-296M-134M-11M30M3M
Pretax Income-65M-317M-234M-166M73M318M290M399M
Pretax Margin %-1.22%-6.21%-4.88%-4%1.94%8.45%8.5%10.56%
Income Tax102M35M71M82M58M125M307M96M
Effective Tax Rate %-156.92%-11.04%-30.34%-49.4%79.45%39.31%105.86%24.06%
Net Income-167M-360M-317M-260M6M182M-18M298M
Net Margin %-3.14%-7.06%-6.62%-6.27%0.16%4.83%-0.53%7.89%
Net Income Growth %38.83%-13.56%-21.92%-4433.33%-96.7%1111.11%-106.04%-
Net Income (Continuing)-167M-352M-305M-248M15M193M-17M303M
Discontinued Operations00000000
Minority Interest68M71M71M70M68M73M70M73M
EPS (Diluted)-0.47-1.02-0.90-0.740.040.52-0.050.85
EPS Growth %38.37%-13.33%-21.62%-1824.94%-91.75%1169.96%-105.72%-
EPS (Basic)--1.02-0.90-0.740.040.52-0.050.85
Diluted Shares Outstanding357.1M353.8M351.8M350.5M350M350M350M350M
Basic Shares Outstanding357.1M353.8M351.8M350.5M350M350M350M350M
Dividend Payout Ratio--------

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Persistent net losses despite growth

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Momentum Building Steadily

BLCO's revenue grew 8.7% year-over-year in 2026Q2, accelerating from 5.1% in 2025Q2, according to the latest quarterly report, suggesting sustained demand across its portfolio.

The sequential acceleration from 5.1% to 8.7% over four quarters indicates improving commercial execution, likely driven by new product launches and market share gains in vision care. However, growth remains below the 17-19% rates seen in early 2024, implying a normalization from post-pandemic rebound to a more sustainable mid-single-digit to low-double-digit trajectory. Investors should monitor whether this pace can be maintained without additional M&A.

Gross Margin Recovery Underway

Gross margin expanded to 59.1% in 2026Q2 from 53.7% a year earlier, as reported in financial statements, reflecting improved product mix and cost efficiencies, though still below the 61% peak of 2024.

The 540 basis point year-over-year improvement suggests pricing power and favorable mix shifts toward higher-margin surgical and vision care products. However, the margin remains below the 60.9-61.4% range achieved in early 2024, indicating lingering input cost pressures or competitive discounting. The sustainability of this recovery hinges on raw material costs and the ability to pass through price increases without volume loss.

Operating Leverage Emerging but Inconsistent

Operating income swung from a -$61M loss in 2025Q1 to $83M in 2026Q2, per SEC filings, as revenue growth outpaced SG&A growth, but the 6.0% operating margin remains thin.

The positive operating leverage is evident: revenue grew 8.7% while SG&A grew only 1.6% year-over-year in 2026Q2, driving a dramatic improvement in operating income. However, the operating margin is still below the 11.2% achieved in 2025Q4, suggesting that cost control is not yet consistent. The company appears to be in a transition phase where fixed costs are being absorbed, but any revenue hiccup could quickly erode profitability.

Net Losses Persist Despite Operational Gains

BLCO reported a net loss of -$10M in 2026Q2, improving from -$62M a year earlier, but still negative, as per the income statement, indicating below-the-line items continue to weigh on profitability.

Despite positive operating income of $83M, net income remains negative, suggesting significant interest expense, taxes, or other non-operating charges. The diluted EPS of -$0.04 is a marked improvement from -$0.18, but the persistent losses imply that the company's capital structure or legacy liabilities are absorbing operational gains. Investors should scrutinize the interest coverage and any one-time charges that may be masking underlying earnings power.

SG&A Efficiency Driving Margin Expansion

SG&A as a percentage of revenue fell to 42.9% in 2026Q2 from 45.5% in 2025Q2, based on reported figures, indicating disciplined overhead management despite revenue growth.

The 260 basis point reduction in SG&A intensity suggests management is successfully leveraging its cost base, possibly through restructuring or digital initiatives. R&D spending increased 18.8% year-over-year, signaling continued investment in innovation, which is positive for long-term growth but pressures near-term margins. The balance between cost discipline and R&D investment will be critical to sustaining margin improvement.

2025Q1 Marks the Trough

The most significant inflection occurred in 2025Q1, when operating income hit -$61M and net margin was -18.6%, as per financial statements, followed by a sharp recovery to positive operating income by 2025Q2.

This quarter appears to have been a nadir, likely due to one-time charges or operational disruptions, after which the company staged a robust recovery. The subsequent quarters show a clear upward trend in both gross and operating margins, suggesting that the company addressed structural issues. The lasting impact is a more cost-efficient operating model, but the volatility in 2025Q1 underscores the fragility of the earnings profile.

Persistent Losses Undermine Growth Story

Despite revenue growth and margin expansion, BLCO has not reported a profitable quarter since 2024Q3, with cumulative net losses exceeding $600M over the last eight quarters, per income statement data.

Short-sellers would argue that the company's inability to convert operational improvements into net income signals deeper issues, such as excessive debt or legacy liabilities. The negative EPS in most quarters, despite positive operating income, suggests that interest expenses or other non-operating costs are eroding shareholder value. If these below-the-line costs persist, the stock may remain undervalued, but the risk of dilution or balance sheet restructuring could further pressure equity holders.

BLCO — Frequently Asked Questions

Quick answers to the most common questions about buying BLCO stock.

What was Bausch + Lomb Corporation's (BLCO) revenue in 2025?

For fiscal year 2025, Bausch + Lomb Corporation (BLCO) reported total revenue of $5.10B. This represents a 35.0% increase compared to $3.78B in 2019.

Is Bausch + Lomb Corporation (BLCO) profitable?

Bausch + Lomb Corporation (BLCO) reported a net loss of $360.0M for the fiscal year ending 2025.

What is Bausch + Lomb Corporation's operating profit margin?

Bausch + Lomb Corporation (BLCO) reported an operating income of $188.0M, resulting in an operating profit margin of 3.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Bausch + Lomb Corporation's gross profit and gross margin?

Bausch + Lomb Corporation (BLCO) generated $2.79B in gross profit for the year, representing a gross profit margin of 54.8%. This demonstrates the company's core pricing power and production efficiency.